Intensive care due to myasthenia gravis: Risk factors and prognosis

Chris Myllynen1, Anni Tuulasvaara1,2, Sari Atula1,2

  • 1Department of Neurosciences, University of Helsinki, Helsinki, Finland.

PubMed
Abstract

Insights

Patients with myasthenia gravis (MG) and respiratory failure requiring intensive care are at higher risk if diagnosed later in life, have thymoma, or are female. Early treatment is crucial for better outcomes.

Area of Science:

  • Neurology
  • Critical Care Medicine

Background:

  • Myasthenia gravis (MG) exacerbation with respiratory failure necessitates intensive care.
  • Understanding risk factors and prognosis for intensive care unit (ICU) admission in MG patients is crucial.

Purpose of the Study:

  • To identify risk factors for ICU admission in myasthenia gravis patients.
  • To evaluate the prognosis of people with MG (pwMG) following ICU admission.

Main Methods:

  • Retrospective study of 577 pwMG in the Helsinki and Uusimaa hospital district (2008-2021).
  • Analysis of risk factors for ICU admission compared to outpatient and neurological ward treatment.
  • Comparison of outcomes for MG patients in ICU versus asthma patients in ICU.

Main Results:

  • 6.1% of pwMG required ICU admission, often within 5.3 months of diagnosis.
  • Higher age at diagnosis, thymoma, and female sex were independent risk factors for ICU admission.
  • In-hospital mortality for myasthenic crisis (MC) was 4%; 6-month mortality post-ICU for MG exacerbation was 14.3%.

Conclusions:

  • Late-onset MG, female sex, and thymoma increase the risk of ICU admission.
  • These risk factors often manifest within six months of diagnosis.
  • Emphasizes the importance of timely and appropriate early treatment choices for pwMG.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
673
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
896
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2